Financials
Financial year 2025
THEMAPHARMA from Les Bons Villers, company number BE0436017275, closed financial year 2025 with a result of € -13,646 after tax. For that financial year THEMAPHARMA recorded a gross margin of € 177,330 and equity of € 1.7 million. Compared with financial year 2024, the result moved from € 20,286 to € -13,646. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 1.7 million
▼ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -13,646
▼ still € 20,286 profit in 2024
Profit after tax over the fiscal year.
€ 378,629
▲ 21% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 1.7 million.
People and assets in 2025
€ 2,217
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 9,668
▼ 43% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 2.3 million
▼ 5% vs 2024
€ 121,192 is repaid this year. At this pace the long-term loan is gone in ≈ 19 years.
€ 5,372
▼ 85% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 29,885
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 190,541 | € 180,980 | € 233,388 | € 177,330 | ▼ 24% |
| Profit after taxes | € -20,844 | € -16,431 | € 20,286 | € -13,646 | ▼ € 33,932 |
| Equity | € 1,714,904 | € 1,698,474 | € 1,718,760 | € 1,705,114 | ▼ 1% |
| Total debts | € 2,809,062 | € 2,568,728 | € 2,948,769 | € 2,340,813 | ▼ 21% |
| Cash | € 192,194 | € 263,249 | € 312,493 | € 378,629 | ▲ 21% |
| Land & buildings | € 2,681,158 | € 2,688,005 | € 2,590,133 | € 2,494,837 | ▼ 4% |
| Retained profit | € 1,696,304 | € 1,679,874 | € 1,700,160 | € 1,686,514 | ▼ 1% |
| Bank debt | € 2,720,582 | € 2,531,384 | € 2,416,752 | € 2,303,532 | ▼ 5% |
| Balance sheet total | € 4,784,556 | € 4,518,475 | € 4,909,482 | € 4,278,562 | ▼ 13% |
Key figures of THEMAPHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to THEMAPHARMA?
What happened at THEMAPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 13,646 (▼ € 33,932 vs 2024). filed late Source: NBB ↗
- New establishment in Les Bons Villers. KBO
- Start of the company according to the CBE. KBO
In short
From € 20,844 loss in 2022 to € 13,646 loss in 2025.
Paid € 99,349 in corporate taxes since 2022.
Best year ever: 2024, with € 20,286 profit.
A new publication or filing at THEMAPHARMA? We notify you, reason included.
Follow THEMAPHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind THEMAPHARMA is Laurence BARBARIN. Laurence BARBARIN is also behind PHARMACIE BARBARIN LAURENCE.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Rue d'En-dessous(MEL) 41 box e
6211 Les Bons Villers
Rue d'En-dessous(MEL) 41 box E
6211 Les Bons Villers
Active since 20 December 1988
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0436.017.275
- VAT number
- BE 0436.017.275
- Registered office
- Rue d'En-dessous(MEL) 41 bus e, 6211 Les Bons Villers
- Names & denominations
- THEMAPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 December 1988
- Peppol
- Active · Active since 9 Dec 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Ontwikkeling van residentiële bouwprojecten
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Bemiddeling in verband met exploitatie van en handel in onroerend goed
Bemiddeling bij de aankoop, verkoop en verhuur van onroerend goed voor een vast bedrag of op contractbasis
Adviesbureaus op het gebied van public relations en communicatie